Patent application number | Description | Published |
20090123931 | IDENTIFICATION OF TISSUE FOR DEBRIDEMENT - Provided are methods of determining whether a cell in a tissue site is viable or nonviable. Also provided are methods of debriding tissue from a tissue site. Further provided are kits comprising a compound that distinguishes between viable and nonviable cells and instructions for using the compound on a tissue site. Additionally, the use of a compound that distinguishes between viable and nonviable cells is provided, where the use is to determine whether a cell in a tissue site is viable or nonviable. Also provided is a use of a compound that distinguishes between viable and nonviable cells, where the use is for the manufacture of the above-described kit. | 05-14-2009 |
20090177133 | Reduced pressure dressing coated with biomolecules - A reduced pressure dressing coated with biomolecules including a polymer material layer and at least one biomolecule selected from the group consisting of a hemostatic agent, an antioxidant agent, and a nitric oxide promoter, the at least one biomolecule absorbed into a portion of the polymer material layer. The present reduced pressure dressing coated with biomolecules further includes methods for making same. | 07-09-2009 |
20090216170 | SYSTEM AND METHOD FOR HEALING A WOUND AT A TISSUE SITE - Provided herein is a system and method for facilitating removal of a drape from a tissue site. One aspect provides a system comprising a drape, and adhesive layer, and a release agent, where the system is adapted to be coupled to a tissue site and released therefrom upon or after exposure to an external stimulus. Another aspect provides a method for application and removal of a drape using less force than required with a conventional drape. | 08-27-2009 |
20090275884 | USE OF NUCLEIC ACIDS WITH REDUCED PRESSURE THERAPY - Provided is a method of treating a wound site. Also provided is a system for treating a wound site. Additionally provided is the use of reduced pressure and a nucleic acid that promotes wound healing for treatment of a wound site. Further provided is the use of a nucleic acid that promotes wound healing for the manufacture of a medicament for treating a wound site that is undergoing reduced pressure treatment. | 11-05-2009 |
20090326416 | DETECTING INFECTION IN REDUCED PRESSURE WOUND TREATMENT - Provided is a method of detecting infection in a wound caused by an infecting organism at a wound site. Also provided is a system for detecting an infection in a wound at a wound site. Additionally, a porous pad comprising luciferase is provided. | 12-31-2009 |
20110040221 | System and Method to Reduce Stasis-Induced Reperfusion Injury - A system and method for reducing or preventing stasis-induced ischemia reperfusion injury to a tissue. The system and method may vary a pressure exerted on a tissue to generate a physiological response in the tissue. The physiological response may include the production of an antioxidant. The system and method may introduce a pharmacological agent to increase blood flow to the tissue. | 02-17-2011 |
20120003677 | IDENTIFICATION OF TISSUE FOR DEBRIDEMENT - Provided are methods of determining whether a cell in a tissue site is viable or nonviable. Also provided are methods of debriding tissue from a tissue site. Further provided are kits comprising a compound that distinguishes between viable and nonviable cells and instructions for using the compound on a tissue site. Additionally, the use of a compound that distinguishes between viable and nonviable cells is provided, where the use is to determine whether a cell in a tissue site is viable or nonviable. Also provided is a use of a compound that distinguishes between viable and nonviable cells, where the use is for the manufacture of the above-described kit. | 01-05-2012 |
20120129186 | DEVICES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF WOUNDS USING BIOMARKERS - The present invention provides for devices and methods for determining the healing phase of a wound. In some aspects, the present invention provides a wound diagnosis device comprising a surface and at least one agent that is specific to a desired biomarker. In another aspect, the present invention provides a method of determining the phase of wound healing. In still other aspects, the present invention provides methods of determining the phase of wound healing using the disclosed devices. | 05-24-2012 |
20120244526 | IDENTIFICATION OF TISSUE FOR DEBRIDEMENT - Provided are methods of determining whether a cell in a tissue site is viable or nonviable. Also provided are methods of debriding tissue from a tissue site. Further provided are kits comprising a compound that distinguishes between viable and nonviable cells and instructions for using the compound on a tissue site. Additionally, the use of a compound that distinguishes between viable and nonviable cells is provided, where the use is to determine whether a cell in a tissue site is viable or nonviable. Also provided is a use of a compound that distinguishes between viable and nonviable cells, where the use is for the manufacture of the above-described kit. | 09-27-2012 |